Virtu KCG Holdings’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-21,227
| Closed | -$178K | – | 2877 |
|
|
2017
Q1 | $178K | Sell |
21,227
-8,014
| -27% | -$67.2K | ﹤0.01% | 2468 |
|
|
2016
Q4 | $185K | Sell |
29,241
-3,083
| -10% | -$19.5K | ﹤0.01% | 2618 |
|
|
2016
Q3 | $143K | Buy |
32,324
+21,813
| +208% | +$96.5K | ﹤0.01% | 2502 |
|
|
2016
Q2 | $30K | Sell |
10,511
-17,653
| -63% | -$50.4K | ﹤0.01% | 2739 |
|
|
2016
Q1 | $80K | Buy |
+28,164
| New | +$80K | ﹤0.01% | 2361 |
|
|
2015
Q2 | – | Sell |
-13,637
| Closed | -$123K | – | 2805 |
|
|
2015
Q1 | $123K | Buy |
+13,637
| New | +$123K | ﹤0.01% | 2096 |
|
|
2014
Q4 | – | Sell |
-43,216
| Closed | -$422K | – | 2818 |
|
|
2014
Q3 | $422K | Buy |
43,216
+28,895
| +202% | +$282K | 0.01% | 1286 |
|
|
2014
Q2 | $182K | Buy |
+14,321
| New | +$182K | ﹤0.01% | 2127 |
|
|
2013
Q4 | – | Sell |
-11,614
| Closed | -$85K | – | 2556 |
|
|
2013
Q3 | $85K | Buy |
+11,614
| New | +$85K | ﹤0.01% | 2308 |
|